Integrating the Youth Nominated Support Team (YST) With CBT for Black Youth With Acute Suicide Risk: Aim 2b

March 26, 2026 updated by: Cynthia Ewell Foster, University of Michigan

Integrating the Youth Nominated Support Team (YST) With CBT for Black Youth With Acute Suicide Risk

This is a second pilot study being completed based on lessons learned from the Aim 2a feasibility pilot study (NCT06941311). Following modifications, the investigators are testing the acceptability, feasibility, and preliminary effectiveness of the combination of two psychosocial interventions, Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP) and the computer-assisted version of the Youth-Nominated Support Team (eYST).

In this phase of the study, CBT-SP + eYST will be tested in an open trial (number of youth = 15). Investigators will recruit Black adolescents (ages 12-17) that come to an urban acute care setting for suicidal thoughts and/or self-injurious behaviors to receive the intervention in an outpatient community mental health agency. Participants will receive 12-14 sessions of CBT-SP in addition to YST. Participants will nominate up to 5 caring adults in their lives to serve as support persons. These support persons will attend an education/orientation session to learn more about their role and how to support the youth. Support persons will have weekly contact with the youth and weekly follow up contacts from the youth's clinician/YST intervention specialist.

Youth will be assessed at baseline, 6 weeks, and 14 weeks. Parents will be assessed at baseline and 14 weeks. Support persons will be assessed at baseline and 14 weeks.

Fidelity assessments will be completed by clinicians after each session, after the YST psycho-ed session, and weekly to document contact with the support team.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United States
    • Michigan
      • Detroit, Michigan, United States, 48201
        • Recruiting
        • Children's Hospital of Michigan (CHM) Emergency Department
        • Principal Investigator:
          • Curt Stankovic, MD
        • Contact:
      • Detroit, Michigan, United States, 48210
        • Recruiting
        • MiSide
        • Contact:
        • Principal Investigator:
          • Marquita Felder, LMSW

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Youth Inclusion Criteria:

  • Patients that are able to provide at least one verifiable contact for emergency or tracking purposes
  • Willing to receive care at MiSide
  • Present to an acute emergency care setting with suicide risk (per protocol)
  • Self-identify as Black
  • Willing and able to complete enrollment procedures
  • Willing and able to provide signed and dated informed assent

Youth Exclusion Criteria:

  • Unable to be consented in English
  • Do not have a parent/legal guardian available to provide consent
  • Are not able to provide informed assent or to participate in the assessment due to significant agitation, psychosis, cognitive impairment, learning disability, or medical trauma
  • Actively engaged in specialty mental health treatment
  • Participated in the Aim 2a open trial

Parent/Guardian Inclusion Criteria:

  • Adults 18 years and older
  • The parent or legal guardian of a youth participating in this Aim
  • Understand written and spoken English
  • Willing and able to complete enrollment procedures
  • Willing and able to provide signed and dated informed consent
  • Need to have access to technology, either cell or an email address

Parent/Guardian Exclusion Criteria:

- Do not understand written and spoken English

Support Person Inclusion Criteria:

  • Adults 18 years and older
  • Understand written and spoken English
  • Approved to serve as a support person by the parent/legal guardian

Support Person Exclusion Criteria:

  • Do not understand written and spoken English
  • Not approved to serve as a support person by the parent/guardian

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CBT for Suicide Prevention plus the Youth-Nominated Support Team
Participation will be 3 months.
Behavioral: Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP)
Clinicians will provide this specialized evidence based mental health care. The study focuses on the acute phase of CBT-SP, which is 12 sessions. CBT-SP's goals are to reduce suicide risk factors, enhance coping, and prevent future suicidal behavior. Identifying the emotional, cognitive, behavioral, or familial processes that precede a suicide crisis is a major focus, which yields an individualized treatment plan. Each session lasts one hour and can be completed either in person or via a secure telehealth platform. Most youths will attend sessions on a weekly basis and therapists will prioritize parent engagement
Behavioral: Youth-Nominated Support Team
Youth will nominate up to 5 trusted adults. Following parental approval, Support Persons will attend a psychoeducational orientation session with their assigned intervention specialist (i.e., the youth's clinician), learn about the youth's difficulties, treatment plan, and receive ideas for supporting the youth. Support Persons will be asked to have contact with the youth each week for the 3 months of the study. During these calls, Support Persons have an opportunity to discuss any questions or concerns they may have about the youth and how best to support them.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility - Mean number of support people
Time Frame: 6 weeks
The intervention will be considered feasible if the mean number of support people per youth is at least 3.
6 weeks
Acceptability - Mean number of support person contacts
Time Frame: 14 weeks
The intervention will be considered acceptable if the mean number of support person contacts with youth is at least 7.
14 weeks
Feasibility - Number of CBT-SP sessions attended
Time Frame: 14 weeks
Number of CBT-SP sessions attended by youth
14 weeks
Acceptability - percent of eligible youth consented
Time Frame: Baseline
The intervention will be considered acceptable if at least 50% of eligible youth approached for participation choose to enroll in the study.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Michigan

Collaborators

National Institute of Mental Health (NIMH)
Children's Hospital of Michigan
MiSide

Investigators

  • Principal Investigator: Cynthia Ewell Foster, PhD, University of Michigan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 23, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

March 26, 2026

First Submitted That Met QC Criteria

March 26, 2026

First Posted (Actual)

April 1, 2026

Study Record Updates

Last Update Posted (Actual)

April 1, 2026

Last Update Submitted That Met QC Criteria

March 26, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HUM00225071b
  • 5R34MH131722-02 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Upload to National Institute of Mental Health (NIMH) Data Archive.

IPD Sharing Time Frame

After the study is completed and available according to NIMH Data Archive policy.

IPD Sharing Access Criteria

Researchers can request de-identified data from the study contacts listed in the study.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Behavioral Symptoms

Clinical Trials on Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe